Stay updated on SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.

Latest updates to the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe SWIPE study page now presents a 403 error page, replacing the previously visible trial details and identifiers with a generic error screen, effectively hiding the study information from the public view.SummaryDifference18%

- Check41 days agoChange DetectedRevision: v3.6.6 appears, replacing the previous v3.6.5 to indicate an updated page version; this reflects a maintenance/update to the page's metadata rather than substantive content changes.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page's revision tag has been updated to v3.6.5, replacing the previous v3.6.4, indicating a small editorial or system update to the study page.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a small update to the page metadata. This does not change the study details or how to participate.SummaryDifference0.1%

- Check99 days agoChange DetectedThe page metadata was updated from revision v3.6.2 to v3.6.3, indicating a behind-the-scenes update; the visible study information remains unchanged.SummaryDifference0.1%

- Check106 days agoChange DetectedThe page now shows revision v3.6.2, replacing the previous v3.6.0. This indicates a refreshed version of the study page has been published.SummaryDifference0.1%

Stay in the know with updates to SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.